Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The…
Weekly updates from the National Comprehensive Cancer Network share every time a change is made to evidence-based, expert consensus-driven guidelines…
Study now open for enrollment at leading academic medical centersCARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity…
Non-Invasive High Precision Therapy with Linear Accelerator (LINAC)AHMEDABAD, India, May 19, 2026 /PRNewswire/ -- Zydus Cancer Hospital, Ahmedabad, successfully performs over 200 Non-Invasive…
SINGAPORE, May 18, 2026 /PRNewswire/ -- AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to…
More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC aloneDeep…
Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on…
LONDON, May 13, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership…
May 08, 2026 20:45 ET | Source: Amplia Therapuetics Limited Melbourne, Australia, May 08, 2026 (GLOBE NEWSWIRE) -- HIGHLIGHTS Amplia…
Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and…